Pharmacy Reviews in Workers Compensation Disputes and Litigation
How independent medication reviews provide objective evidence in claims disputes, tribunal proceedings, and Section 60 litigation
Published: 4 April 2026
Introduction: Pharmacy Reviews as Dispute Evidence
Pharmacy reviews are increasingly used in workers compensation disputes and litigation to analyse medication appropriateness, identify high-risk prescribing patterns, and manage claims costs. As an insurer or claims manager, you face a consistent challenge: distinguishing between necessary, evidence-based treatment and inappropriate medication use that extends recovery timeframes and inflates claims expenses.
An independent pharmacy review provides objective, clinically defensible evidence to support your position in disputes. Whether you're contesting treatment under Section 60 of the Workers Compensation Act 1987 (NSW), investigating non-PBS prescribing, or building a litigation strategy, a pharmacy review report from a qualified pharmacist strengthens your case in tribunals and before legal representatives.
Key takeaway: Pharmacy reviews deliver independent expert evidence on medication appropriateness, high-risk prescribing, dispensing errors, and cost-benefit analysis. This evidence carries significant weight in workers compensation disputes, Personal Injury Commission proceedings, and Workers Compensation Commission hearings across Australian states.
Why Pharmacy Reviews Matter in Workers Compensation Disputes
Assessing "Reasonably Necessary" Treatment Under Section 60
The cornerstone of workers compensation legislation across Australian states is the concept of "reasonably necessary" treatment. Section 60 of the Workers Compensation Act 1987 (NSW) defines the insurer's obligation: they must pay for medical and related treatment that is "reasonably necessary" to promote recovery from the injury.
The challenge is determining what "reasonably necessary" means in the context of medication. Is a claimant on three concurrent opioid medications acting appropriately, or has prescribing escalated unnecessarily? Is a benzodiazepine continuation justified two years post-injury, or is it now creating dependence? These questions require expert judgment grounded in evidence-based practice, prescribing guidelines, and clinical pharmacy principles.
A pharmacy review answers these questions objectively. Your pharmacist reviewer examines the medication history against current clinical guidelines, assesses whether each medication addresses an identified clinical need, and evaluates whether the combination of medications creates safety risks or contradicts evidence-based practice. This analysis forms the clinical foundation for your Section 60 dispute.
High-Risk Medication Monitoring and Identification
Certain medication classes carry elevated risk in workers compensation claims. Opioid medications, benzodiazepines, Z-drugs (zopiclone, zolpidem), and gabapentinoids (pregabalin, gabapentin) require particular scrutiny because they are frequently associated with dependence, adverse effects, and poor recovery outcomes.
Your claims data may reveal that claimants on long-term opioid therapy experience extended claims duration, delayed return to work, and increased health service utilisation. A pharmacy review identifies which claimants are on high-risk medication combinations and flags prescribing patterns that deviate from best practice. This allows you to intervene early, refer for specialist medical review, or challenge ongoing prescriptions that no longer serve the claimant's recovery.
Non-PBS Prescriptions and Unjustified Private Prescribing
Non-PBS (private) prescriptions present a specific concern in workers compensation claims. When a prescriber issues a private prescription instead of a PBS (Pharmaceutical Benefits Scheme) prescription, they bypass authority requirements that exist to ensure appropriate use. Non-PBS prescribing is more expensive (no subsidy), harder to track, and sometimes signals prescribing that would not meet PBS authority criteria.
A pharmacy review investigates non-PBS prescriptions by examining clinical justification. Is the medication genuinely unavailable on the PBS, or is the prescriber avoiding authority requirements? Is the dose or frequency clinically justified? Are there cost implications that suggest unnecessary private prescribing? This analysis equips you to challenge reimbursement or escalate to the treating medical team.
Dispensing Errors, Prescribing Errors, and Negligence
Medication errors, whether in prescribing or dispensing, can cause adverse outcomes, extend recovery, and create liability questions. Has a pharmacy dispensed the wrong dose, issued an expired medication, or failed to flag a dangerous drug interaction? Has a doctor prescribed an inappropriate medication or dosage for the identified injury?
A pharmacy review identifies these errors retrospectively through systematic analysis of medication records. In dispute or litigation contexts, this evidence is critical: it documents what happened, who was responsible, and what impact the error had on the claimant's recovery. This becomes crucial if negligence is alleged or if the claim's trajectory was altered by medication error.
Impact on Claims Management and Litigation Outcomes
Reducing Over-Utilisation and Medication Burden
Research in medication review practice consistently shows significant reductions in medication burden following pharmacy intervention. In workers compensation populations, opioid cessation rates of 43% and reductions in benzodiazepine use of 30-40% are typical outcomes when pharmacy reviews identify unnecessary or inappropriate medications.
For your claims management position, this means that a pharmacy review identifying unnecessary medications is not merely an administrative action; it is a clinical intervention with demonstrated efficacy. When you present this evidence in a dispute, you are not simply disagreeing with the treating practitioner; you are presenting objective evidence of over-medication that contradicts best practice.
Speeding Recovery and Return to Work
Excessive medication, particularly opioids and benzodiazepines, delays recovery and extends time away from work. Claimants on high-dose opioid therapy or long-term benzodiazepines experience slower functional recovery, higher fall risk, cognitive impairment, and reduced participation in rehabilitation. A pharmacy review that identifies and addresses these issues accelerates recovery and return to work, reducing overall claims costs.
In litigation, this becomes a powerful narrative: by identifying inappropriate prescribing and optimising medication, you are supporting the claimant's recovery while controlling costs. This positions your dispute not as a refusal to fund treatment, but as evidence-based claims management aligned with the claimant's best interests.
Cost Reduction Through Identification of Unnecessary Medications
Unnecessary medications represent direct cost. Non-PBS prescriptions, duplicate therapies, medications addressing adverse effects of other medications rather than the original injury, and long-term prescriptions that no longer serve the claimant all inflate costs without clinical benefit.
A pharmacy review quantifies these costs and identifies which medications should be ceased, deprescribed, or substituted for more cost-effective alternatives. This evidence supports your cost management position in disputes and demonstrates to tribunals and legal representatives that you are making defensible, cost-conscious decisions grounded in clinical pharmacy analysis.
Strengthening Litigation Position With Independent Expert Evidence
In contested disputes and litigation, independent expert evidence carries weight. A pharmacy review from a qualified, independent pharmacist is not a claim from the insurer; it is objective expert assessment. When disputes escalate to the Personal Injury Commission, Workers Compensation Commission, or legal proceedings, this evidence directly challenges claimant arguments or supporting medical reports.
The independence and clinical rigor of a pharmacy review makes it compelling evidence in tribunal proceedings. Your legal representative can present the pharmacy review report as expert evidence, and the reviewer can provide expert testimony on medication appropriateness, guideline compliance, and safety concerns. This shifts the dispute from cost-control position to clinical position.
How to Use Pharmacy Review Evidence in Disputes
Building the Dispute Case
When you decide to dispute a claim or contest treatment, the pharmacy review becomes a cornerstone of your case preparation. Use the review to:
- Identify the specific medications that are clinically inappropriate or unnecessary for the injury
- Reference evidence-based guidelines that do not support the current regimen
- Quantify cost implications of the current prescribing
- Assess whether the medication regimen contradicts the claimant's stated functional capacity
- Flag safety concerns that justify intervention on clinical grounds, not cost grounds
This preparation ensures your dispute is defensible and grounded in clinical evidence, not cost minimisation alone.
Negotiating With Treating Practitioners
A pharmacy review often becomes the basis for productive conversation with the treating doctor or pharmacist. Rather than simply refusing to fund a medication, you present expert analysis showing why the medication is inappropriate or unnecessary. Many treating practitioners welcome this feedback; it supports their own clinical decision-making and provides independent validation.
Use the pharmacy review to propose deprescribing plans, dose reductions, or substitutions that align with best practice. This collaborative approach often resolves disputes without formal proceedings.
Supporting Tribunal and Legal Proceedings
If a dispute escalates to tribunal or legal proceedings, the pharmacy review becomes expert evidence. Your legal team can submit it in written form and may call the pharmacist as an expert witness. The clarity and clinical authority of a well-prepared pharmacy review significantly strengthens your case in these formal settings.
Standards of Evidence: What Makes Pharmacy Review Credible
Independence
The reviewer must be independent from the treating team, the prescriber, and the insurer's initial decision-making. The reviewer should have no financial interest in the outcome and should apply consistent, objective standards. Independence is essential for the evidence to carry weight in tribunal proceedings.
Methodology
A credible pharmacy review follows a transparent, systematic methodology. The reviewer should explain what information was reviewed (medication records, dosing history, clinical notes if available), what guidelines or standards were applied, and how conclusions were reached. This methodological transparency allows your legal team to defend the review against challenge.
Clinical Basis
Conclusions must be grounded in clinical pharmacy principles, evidence-based practice, and relevant guidelines (TGA guidance, SIRA resources, professional standards from the Australian Pharmacy Council, relevant specialty guidelines). Opinions unsupported by clinical evidence or professional standards will not withstand tribunal scrutiny.
Scope Definition
The review scope should be clearly defined: which medications are being reviewed, what time period is covered, what clinical questions are being addressed. This clarity prevents disputes about what the review covered and ensures it addresses your specific litigation concerns.
| Dispute Type | Pharmacy Review Role | Key Evidence |
|---|---|---|
| Section 60: Medication Not Reasonably Necessary | Assess clinical appropriateness against guidelines, injury, and recovery trajectory | Guideline non-compliance, lack of clinical justification, safety concerns |
| High-Risk Prescribing (opioids, benzodiazepines) | Identify inappropriate high-dose therapy, long-term prescribing without review | Dosing exceeds guidelines, lack of documented clinical review, dependence risk |
| Non-PBS Private Prescriptions | Examine justification for private rather than PBS prescribing | Would PBS authority be granted; clinical justification for higher cost |
| Dispensing or Prescribing Error | Identify error, assess impact on claimant outcome | Nature of error, causation link to adverse outcome, liability assessment |
| Cost Management and Over-Medication | Identify unnecessary, duplicate, or low-benefit medications | Medications not addressing injury; cost reduction opportunity; safety benefit |
| Treatment Refusal or Modification | Support decision to refuse funding or demand modification | Clinical evidence for refusal; identification of appropriate alternative |
The Workflow: From Identifying the Dispute to Using Pharmacy Review Evidence
Step 1: Identify the Dispute Trigger
You notice an inconsistency, concern, or cost driver. Perhaps the claimant is on three opioid medications concurrently. Perhaps non-PBS prescriptions are being issued without clear justification. Perhaps a medication was dispensed at an unusual dose. Perhaps the medication regimen seems inconsistent with the claimant's stated functional capacity. This observation becomes your trigger to refer for pharmacy review.
Step 2: Define the Review Scope
Be specific about what you want the reviewer to assess. Are you asking about a single medication, the entire regimen, or specific concern areas? What time period should be covered? What clinical questions should the review address (appropriateness, safety, cost-effectiveness, guideline compliance)? Clear scope definition ensures the review addresses your dispute concern.
Step 3: Obtain the Pharmacy Review
Engage an independent clinical pharmacist to conduct the review. Provide available medication records, dosing history, and any relevant clinical information (injury type, recovery timeline, functional status if documented). The reviewer should apply evidence-based standards and produce a written report with clear conclusions and recommendations.
Step 4: Analyse and Interpret the Review
Once you receive the report, analyse the findings in the context of your dispute. Does the reviewer agree that medication is inappropriate? What specific guideline or clinical principle supports the conclusion? Are there alternative explanations the treating practitioner might offer? Anticipate challenges to strengthen your case.
Step 5: Communicate Findings to Relevant Parties
Share the pharmacy review findings with the claimant, treating practitioners, and legal team (if proceedings are underway). Frame the review as objective clinical analysis, not cost-control action. Use it as basis for discussion with the treating doctor about medication optimisation.
Step 6: Escalate to Dispute or Tribunal if Necessary
If the treating practitioner does not agree to medication changes, escalate the dispute formally. Provide the pharmacy review report as supporting evidence. If proceedings reach tribunal, the review becomes expert evidence that can be submitted in writing or with expert witness testimony.
Pharmacy Reviews and Section 60 Disputes
Section 60 disputes often centre on whether treatment is "reasonably necessary." A pharmacy review directly addresses this question by examining whether the medication regimen, in its current form, represents reasonably necessary treatment for the injury and recovery.
Consider a scenario: a claimant injured in a workplace accident is on opioid therapy at a dose that exceeds guidelines, combined with benzodiazepines for "anxiety" (which may be benzodiazepine-induced rather than injury-related), and multiple other medications. The treating doctor argues all are necessary. You dispute the necessity.
A pharmacy review examines each medication against current evidence, your state's Workers Compensation Act definition of "reasonably necessary," and best-practice guidelines. The reviewer identifies which medications are genuinely necessary for the injury, which are addressing side effects of other medications, and which contradict evidence-based practice. This clinical analysis becomes the foundation for your Section 60 dispute and significantly strengthens your case if it proceeds to tribunal.
Pharmacy Reviews in Personal Injury Commission and Workers Compensation Commission Proceedings
The Personal Injury Commission (NSW) and equivalent Workers Compensation Commission bodies in other states accept pharmacy review evidence in proceedings. However, the evidence must meet evidentiary standards: it must be from a qualified expert, based on reliable methodology, and relevant to the dispute.
Your legal team should prepare the pharmacy review evidence carefully for tribunal submission. This includes ensuring the reviewer is qualified to give expert evidence, the methodology is transparent and defensible, and the conclusions directly address the tribunal's question (e.g., "Is this medication reasonably necessary under Section 60?").
When to Refer for Pharmacy Review: Practical Indicators
You should consider a pharmacy review in these situations:
- Claimant is on long-term high-dose opioid therapy without documented clinical review or deprescribing plan
- Concurrent benzodiazepine and opioid prescribing without clear clinical justification
- Non-PBS prescriptions without documented clinical justification for higher cost or unavailability on PBS
- Polypharmacy where you suspect medications are addressing side effects of other medications
- Medication regimen inconsistent with stated functional capacity (claimant reports good recovery but takes sedating medications)
- Long-term prescriptions that were originally short-term without documented review or weaning plan
- Suspected dispensing error or prescribing error affecting claimant outcome
- Section 60 dispute where you need objective clinical evidence on medication appropriateness
- Litigation or tribunal proceedings where medication appropriateness is disputed
Key Takeaways for Claims Managers
Pharmacy reviews transform medication disputes from cost-control arguments into clinical evidence-based positions. By obtaining independent expert analysis of medication appropriateness, you strengthen your claims management position in disputes, tribunals, and litigation.
The evidence is clear: inappropriate prescribing, polypharmacy, and high-risk medication combinations delay recovery, increase costs, and create liability. Pharmacy reviews identify these issues objectively and equip you with clinical grounds to intervene, optimise medication regimens, and manage costs defensibly.
Whether you are managing a Section 60 dispute, investigating non-PBS prescribing, addressing high-risk medications, or building a litigation case, a pharmacy review provides the independent expert evidence needed to strengthen your position and support evidence-based claims outcomes.
Ready to strengthen your dispute position with independent pharmacy review evidence?
IMM provides specialist pharmacy reviews for workers compensation, CTP, life insurance, and NDIS claims. Our pharmacists deliver objective, tribunal-ready evidence that supports your claims management decisions.
Learn about IMM pharmacy reviews
